Medical Hypotheses
Volume 55, Issue 6 , Pages 459-460 , December 2000

Blood-specific whole-body electromagnetic hyperthermia

  • M. Babincová

      Affiliations

    • Department of Biophysics and Chemical Physics, Comenius University, MFF UK, Bratislava, Slovakia
    • ,
  • P. Sourivong

      Affiliations

    • Physics Department, University of North Dakota, Grand Fork, North Dakota, USA
    • ,
  • D. Leszczynska

      Affiliations

    • Department of Civil Engineering, FAMU-FSU College of Engineering, Tallahassee, Florida, USA
    • ,
  • P. Babinec

      Affiliations

    • Department of Biophysics and Chemical Physics, Comenius University, MFF UK, Bratislava, Slovakia

Received 21 June 1999 ,Accepted 22 November 1999.

References 

    REFERENCES
  1. Page RL, Thrall DE, Dewhirst MW, Meyer RE. Whole-body hyperthermia. Rationale and potential use for cancer treatment. J Vet Intern Med. 1987;1:110–120
  2. Lele PP. A strategy for localized chemotherapy of tumors using ultrasonic hyperthermia. Ultrasound Med Biol. 1979;5(1):95–96
  3. Sathiaseelan V, Mittal BB, Fenn AJ, Taflove A. Recent advances in external electromagnetic hyperthermia. Cancer Treat Res. 1998;93:213–245
  4. Milligan AJ. Whole-body hyperthermia induction technique. Cancer Res. 1984;44:4869–4872
  5. Eisler K, Hipp R, Gigler S, Lange J. New clinical aspects of whole body hyperthermia. Adv Exp Med Biol. 1990;267:393–398
  6. Coley WB. The treatment of malignant tumors by repeated inoculations of erysipelas with a report of ten original cases. Am J Med Sci. 1893;105:487–499
  7. Stitt JT. Fever versus hyperthermia. Fed Proc. 1979;38:39–43
  8. Jordan A, Wust P, Fähling H, John W, Hinz A, Felix R. Inductive heating of ferrimagnetic particles and magnetic fluids: physical evaluation of their potential for hyperthermia. Int J Hyperthermia. 1993;9:51–68
  9. Babincová M. Microwave induced leakage of magnetoliposomes: Possible clinical implications. Biolectrochem Bioenerg. 1993;32:187–190
  10. Babincová M. Microwave-controlled drug release from magnetoliposomes. Pharmazie. 1995;50:702–704
  11. Babincová M, Babinec P. Controlled drug delivery using magnetoliposomes. Cell Mol Biol Letters. 1997;2:1–10
  12. Bulte JW, de Jonge MW, Kamman RL, Zuiderveen F, The TH, de Leij L, et al. Magnetite as a potent contrast-enhancing agent in magnetic resonance imaging to visualize blood-brain barrier disruption. Acta Neurochir Suppl (Wien). 1993;57:30–34
  13. Molday RS, MacKenzie D. Immunospecific ferromagnetic iron-dextran reagents for the labeling and magnetic separation of cells. J Immunol Methods. 1982;52:353–367
  14. Yatvin MB. An approach to AIDS therapy using hyperthermia and membrane modification. Med Hypotheses. 1988;27:163–165
  15. Owens SD, Gasper PW. Hyperthermic therapy for HIV infection. Med Hypotheses. 1995;44:235–242
  16. Babincová M, Machová M. Magnetoliposomes may be useful for elimination of HIV from infected individuals. Zeit Naturforsch. 1998;53c:935–936

PII: S0306-9877(00)91089-2

doi: 10.1054/mehy.2000.1089

Medical Hypotheses
Volume 55, Issue 6 , Pages 459-460 , December 2000

Article Tools